-
4-({7-chloro-2-methoxybenzo[b]1,5-naphthyridin-10-yl}amino)-2,6-bis(pyrrolidin-1-ylmethyl)phenol; tetrakis(phosphoric acid)
-
ChemBase ID:
121845
-
Molecular Formular:
C29H44ClN5O18P4
-
Molecular Mass:
910.030404
-
Monoisotopic Mass:
909.13203379
-
SMILES and InChIs
SMILES:
c1(c2nc(ccc2nc2c1ccc(c2)Cl)OC)Nc1cc(c(c(CN2CCCC2)c1)O)CN1CCCC1.P(=O)(O)(O)O.P(=O)(O)(O)O.P(=O)(O)(O)O.P(=O)(O)(O)O
Canonical SMILES:
OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.COc1ccc2c(n1)c(Nc1cc(CN3CCCC3)c(c(c1)CN1CCCC1)O)c1c(n2)cc(cc1)Cl
InChI:
InChI=1S/C29H32ClN5O2.4H3O4P/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35;4*1-5(2,3)4/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32);4*(H3,1,2,3,4)
InChIKey:
YKUQEKXHQFYULM-UHFFFAOYSA-N
-
Cite this record
CBID:121845 http://www.chembase.cn/molecule-121845.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
4-({7-chloro-2-methoxybenzo[b]1,5-naphthyridin-10-yl}amino)-2,6-bis(pyrrolidin-1-ylmethyl)phenol; tetrakis(phosphoric acid)
|
|
|
IUPAC Traditional name
|
tetrakis(phosphoric acid); pyronaridine
|
|
|
Synonyms
|
4-((7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino)-2,6-bis(pyrrolidin-1-ylmethyl)phenol tetrakis(phosphate)
|
2-Methoxy-7-chloro-10[3′,5′-bis(pyrrolidinyl-1-methyl-)4′-hydroxyphenyl]aminobenzyl-(b)-1,5-naphthyridine tetraphosphate
|
Pyronaridine tetraphosphate
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
7.969286
|
H Acceptors
|
7
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-1.473129
|
LogD (pH = 7.4)
|
1.9516054
|
Log P
|
4.1956854
|
Molar Refractivity
|
147.7446 cm3
|
Polarizability
|
59.306362 Å3
|
Polar Surface Area
|
73.75 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P0049
|
Biochem/physiol Actions Pyronaridine blocks β-hematin formation in vitro3 and has inhibitory activity toward P-glycoprotein mediated drug resistance.4 Antimalarial used on conjunction with artensunate.5 Pyronaridine has antimalarial activity. It is antagonistic against naphthoquine and dihydroartemisinin2. Pyronaridine blocks β-hematin formation in vitro3 and has inhibitory activity toward P-glycoprotein mediated drug resistance.4 Application Pyronaridine, an acridine derivative, is an antimalarial drug. It is used in China as a treatment for drug-resistant falciparum malaria1. It′s in vitro activities have been studies against Plasmodium falciparum in Cameroon2. |
PATENTS
PATENTS
PubChem Patent
Google Patent